MedPath
HSA Approval

LENTRONAT TABLETS 2.5 mg

SIN14825P

LENTRONAT TABLETS 2.5 mg

LENTRONAT TABLETS 2.5 mg

August 4, 2015

NATCO PHARMA ASIA PTE. LTD.

NATCO PHARMA ASIA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNATCO PHARMA ASIA PTE. LTD.
Licence HolderNATCO PHARMA ASIA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L02BG04

letrozole

Manufacturer Information

NATCO PHARMA ASIA PTE. LTD.

Natco Pharma Limited - Pharma Division

Active Ingredients

Letrozole

2.50mg

Letrozole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.